Get the Stockscreener App
3.365
0.15%
+0.005
After Hours:
3.37
0.005
+0.15%
Aquestive Therapeutics Inc Stock (AQST) Forecast
The Aquestive Therapeutics Inc (AQST) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.9972, representing a -70.37% decrease from the current price of $3.365. The highest analyst price target is $1.8747, and the lowest is $0.1197.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month AQST Price Target
Average 3.1594
(-6.11% Downside)
Is Aquestive Therapeutics Inc (AQST) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 37.65 | Neutral |
| STOCH(9,6) | 28.20 | Neutral |
| STOCHRSI(14) | 0.5976 | Buy |
| MACD(12,26) | -0.1476 | Sell |
| ADX(14) | 19.27 | Neutral |
| William %R | -79.39 | Neutral |
| CCI(14) | -168.05 | Sell |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.9625
Sell
|
3.8058
Sell
|
| MA20 |
3.9913
Sell
|
3.9624
Sell
|
| MA50 |
4.1858
Sell
|
3.8939
Sell
|
| MA100 |
3.2751
Buy
|
3.4338
Sell
|
| MA200 |
2.4943
Buy
|
2.788
Buy
|
Buy: 3
Sell: 7
Neutral: 0
Summary: Sell
According to our latest analysis, AQST could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 9 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on AQST, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 37.65 indicates that AQST is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 28.2 indicates that AQST is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 0.5976 indicates that AQST is oversold. This suggests that AQST price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 19.27 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -168.05 indicates that AQST is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term AQST price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Aquestive Therapeutics Inc financial reports and earnings history, Aquestive Therapeutics Inc (AQST) stock could reach $2.2706 by 2030, $4.5934 by 2040 and $9.5322 by 2050. See the projected annual prices until 2050 of the Aquestive Therapeutics Inc stock below:
- Aquestive Therapeutics Inc (AQST) is expected to reach an average price of $1.4276 in 2035, with a high prediction of $1.3775 and a low estimate of $1.3676. This indicates an $-57.57% rise from the last recorded price of $3.365.
- Aquestive Therapeutics Inc (AQST) stock is projected to chart a bullish course in 2040, with an average price target of $4.4501, representing an $32.25% surge from its current level. The forecast ranges from a conservative $4.5201 to a sky-high $4.5934.
- Our analysts predict Aquestive Therapeutics Inc (AQST) to jump 107.03% by 2045, soaring from $7.1315 to an average price of $6.9666, potentially reaching $7.65. While $7.1315 is the low estimate, the potential upside is significant.
- Aquestive Therapeutics Inc (AQST) stock is expected to climb by 2050, reaching an average of $9.6222, a $185.95% jump from its current level. However, a wide range of estimates exists, with high and low targets of $9.5322 and $8.932, respectively, highlighting the market's uncertainty.
Aquestive Therapeutics Inc Stock (AQST) Year by Year Forecast
Aquestive Therapeutics Inc Stock (AQST) Price Forecast for 2024
Our forecast for AQST stock price in 2024 now indicates an average price target of $2.2037 with a high forecast of $4.3879 and a low forecast of $0.0196. The average prediction reflects an decrease of -34.51% from the last recorded price of $3.365.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $0.2803 | $0.1197 | $1.8747 | -91.67% |
| July, 2024 | $0.9896 | $0.0896 | $1.0096 | -70.59% |
| August, 2024 | $0.4505 | $0.0196 | $0.9696 | -86.61% |
| September, 2024 | $0.0305 | $0.0605 | $0.4445 | -99.09% |
| October, 2024 | $0.7306 | $0.4106 | $0.3656 | -78.29% |
| November, 2024 | $0.5306 | $0.6706 | $0.4906 | -84.23% |
| December, 2024 | $2.3232 | $0.0507 | $2.9192 | -30.96% |
Aquestive Therapeutics Inc Stock (AQST) Price Forecast for 2025
Aquestive Therapeutics Inc Stock (AQST) is expected to reach an average price of $3.1591 in 2025, with a high prediction of $6.2992 and a low estimate of $0.019. This indicates an -6.12% fall from the last recorded price of $3.365.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $1.7292 | $1.4092 | $6.2992 | -48.61% |
| February, 2025 | $2.2192 | $1.4192 | $2.5485 | -34.05% |
| March, 2025 | $0.4891 | $0.1491 | $3.3191 | -85.46% |
| April, 2025 | $0.2291 | $0.0609 | $1.1691 | -93.19% |
| May, 2025 | $1.341 | $1.401 | $1.501 | -60.15% |
| June, 2025 | $0.8389 | $0.019 | $1.361 | -75.07% |
| July, 2025 | $2.3389 | $0.3489 | $3.4789 | -30.49% |
| August, 2025 | $2.0088 | $1.239 | $2.3889 | -40.30% |
| September, 2025 | $1.3788 | $0.6488 | $2.5388 | -59.03% |
| October, 2025 | $3.8287 | $1.4788 | $4.0387 | +13.78% |
| November, 2025 | $3.9687 | $3.3887 | $5.6587 | +17.94% |
| December, 2025 | $1.4486 | $1.1686 | $6.2136 | -56.95% |
Aquestive Therapeutics Inc Stock (AQST) Price Forecast for 2026
The predicted value for Aquestive Therapeutics Inc (AQST) in 2026 is set at an average of $2.6333. Estimates vary from a peak of $4.9684 to a trough of $0.2981, indicating an -21.74% surge from the present price of $3.365.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.6685 | $1.4386 | $2.3585 | -50.41% |
| February, 2026 | $3.9185 | $1.4885 | $4.2585 | +16.45% |
| March, 2026 | $3.2884 | $2.9284 | $4.9684 | -2.28% |
| April, 2026 | $2.6284 | $1.9484 | $3.3884 | -21.89% |
| May, 2026 | $2.6483 | $2.0486 | $3.985 | -21.30% |
| June, 2026 | $1.3482 | $0.9183 | $2.7061 | -59.93% |
| July, 2026 | $1.3282 | $1.0282 | $2.4882 | -60.53% |
| August, 2026 | $0.4981 | $0.2981 | $1.4482 | -85.20% |
| September, 2026 | $1.2481 | $0.4881 | $1.5165 | -62.91% |
| October, 2026 | $0.858 | $0.568 | $1.7781 | -74.50% |
| November, 2026 | $1.1979 | $0.348 | $1.3679 | -64.40% |
| December, 2026 | $1.8379 | $0.8579 | $2.1079 | -45.38% |
Aquestive Therapeutics Inc Stock (AQST) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Aquestive Therapeutics Inc (AQST) is $1.9301, with a high forecast of $3.8477 and a low forecast of $0.0125. This indicates an -42.64% decrease from the last price of $3.365.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1.6978 | $1.3437 | $1.9678 | -49.54% |
| February, 2027 | $1.7048 | $1.0378 | $2.0678 | -49.34% |
| March, 2027 | $3.8077 | $1.7088 | $3.8377 | +13.16% |
| April, 2027 | $3.1777 | $2.0277 | $3.8477 | -5.57% |
| May, 2027 | $0.4776 | $0.4226 | $3.7377 | -85.81% |
| June, 2027 | $0.0975 | $0.0176 | $0.5571 | -97.10% |
| July, 2027 | $0.5075 | $0.0125 | $0.7975 | -84.92% |
| August, 2027 | $0.2274 | $0.0425 | $0.6075 | -93.24% |
| September, 2027 | $0.9026 | $0.0626 | $0.3274 | -73.18% |
| October, 2027 | $1.2327 | $1.1226 | $1.1527 | -63.37% |
| November, 2027 | $1.4728 | $1.2627 | $1.4228 | -56.23% |
| December, 2027 | $1.3033 | $1.4358 | $1.5388 | -61.27% |
Aquestive Therapeutics Inc Stock (AQST) Price Forecast for 2028
In 2028, Aquestive Therapeutics Inc (AQST) is projected to reach an average price of $0.6197, with a high projection of $1.2328 and a low estimate of $0.00655. This indicates an -81.58% fall from the last price of $3.365.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.6929 | $0.7629 | $1.2328 | -79.41% |
| February, 2028 | $0.6229 | $0.8029 | $0.7029 | -81.49% |
| March, 2028 | $0.988 | $0.8699 | $0.8485 | -70.64% |
| April, 2028 | $1.133 | $1.1529 | $1.103 | -66.33% |
| May, 2028 | $1.0251 | $1.0231 | $1.0841 | -69.54% |
| June, 2028 | $0.9832 | $1.0281 | $0.9801 | -70.78% |
| July, 2028 | $0.9766 | $0.9597 | $0.9833 | -70.98% |
| August, 2028 | $1.0094 | $0.9832 | $0.9433 | -70.00% |
| September, 2028 | $0.9896 | $1.0183 | $0.9868 | -70.59% |
| October, 2028 | $0.4634 | $0.6334 | $0.9384 | -86.23% |
| November, 2028 | $0.2765 | $0.00655 | $0.9565 | -91.78% |
| December, 2028 | $0.6065 | $0.2365 | $1.0165 | -81.98% |
Aquestive Therapeutics Inc Stock (AQST) Price Forecast for 2029
The 2029 price forecast for Aquestive Therapeutics Inc Stock (AQST) is $1.0708 on average, with a high prediction of $2.1402 and a low estimate of $0.00136. This represents an -68.18% decrease from the previous price of $3.365.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.0564 | $0.0286 | $0.7065 | -98.32% |
| February, 2029 | $0.6264 | $0.0236 | $0.7064 | -81.39% |
| March, 2029 | $0.2663 | $0.0963 | $0.7364 | -92.09% |
| April, 2029 | $0.1063 | $0.0137 | $0.309 | -96.84% |
| May, 2029 | $0.1062 | $0.0162 | $0.3862 | -96.84% |
| June, 2029 | $0.2861 | $0.00136 | $0.3561 | -91.50% |
| July, 2029 | $0.7561 | $0.1661 | $1.3261 | -77.53% |
| August, 2029 | $2.20 | $0.5161 | $2.03 | -34.62% |
| September, 2029 | $0.5001 | $1.3301 | $0.4001 | -85.14% |
| October, 2029 | $1.8403 | $2.4902 | $2.1402 | -45.31% |
| November, 2029 | $1.7604 | $1.2503 | $0.4903 | -47.69% |
| December, 2029 | $1.8905 | $1.9904 | $1.6705 | -43.82% |
Aquestive Therapeutics Inc Stock (AQST) Price Forecast for 2030
Aquestive Therapeutics Inc Stock (AQST) is expected to reach an average price of $2.3799 in 2030, with a high forecast of $4.3012 and a low forecast of $0.4585. This signifies an -29.28% decrease from the last price of $3.365.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.0306 | $2.5606 | $2.2706 | -9.94% |
| February, 2030 | $4.1482 | $3.4406 | $3.6407 | +23.28% |
| March, 2030 | $2.9608 | $3.7808 | $3.4508 | -12.01% |
| April, 2030 | $4.521 | $3.7209 | $4.271 | +34.35% |
| May, 2030 | $3.8911 | $3.9211 | $3.781 | +15.63% |
| June, 2030 | $4.5512 | $4.2611 | $4.1862 | +35.25% |
| July, 2030 | $4.2413 | $4.4513 | $4.3012 | +26.04% |
| August, 2030 | $1.4075 | $2.0114 | $3.2014 | -58.17% |
| September, 2030 | $1.9516 | $0.4585 | $2.5985 | -42.00% |
| October, 2030 | $0.7117 | $1.6616 | $1.4316 | -78.85% |
| November, 2030 | $3.1118 | $3.2017 | $3.1021 | -7.53% |
| December, 2030 | $5.4019 | $2.9318 | $3.4669 | +60.53% |
0.08%
1.28%
Cap:
|
Volume (24h):